InterVenn is a Biotech company based in San Francisco, California. It has raised $279M in total funding. Latest round: Series C. Backed by SoftBank.
InterVenn funding overview
InterVenn is a Biotech company based in San Francisco, California. InterVenn has raised $279M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in January 2024. The round record for InterVenn runs through 2024; nothing later has been disclosed. Investors on record include SoftBank.
InterVenn at a glance
Total raised
$279M
Latest round
Series C
Latest round date
January 2024
Industry
Biotech
Headquarters
San Francisco, California
Notable investors
SoftBank
Frequently asked about InterVenn funding
How much has InterVenn raised?
InterVenn has raised $279M in total disclosed funding across the rounds on record.
Who has invested in InterVenn?
SoftBank are named among the investors backing InterVenn.
What was the latest InterVenn funding round?
The most recent disclosed round is a Series C, announced in January 2024.
Where is InterVenn based?
InterVenn is based in San Francisco, California.
What sector does InterVenn operate in?
InterVenn is tracked under Biotech from San Francisco, California, with $279M in disclosed funding.
When did InterVenn last raise?
The last disclosed InterVenn round closed in January 2024 at Series C.
Every InterVenn figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in San Francisco at a similar stage.
